[go: up one dir, main page]

MX2009000379A - Preparacion farmaceutica para la administracion oral con liberacion controlada del ingrediente activo en el intestino delgado y metodo para su fabricacion. - Google Patents

Preparacion farmaceutica para la administracion oral con liberacion controlada del ingrediente activo en el intestino delgado y metodo para su fabricacion.

Info

Publication number
MX2009000379A
MX2009000379A MX2009000379A MX2009000379A MX2009000379A MX 2009000379 A MX2009000379 A MX 2009000379A MX 2009000379 A MX2009000379 A MX 2009000379A MX 2009000379 A MX2009000379 A MX 2009000379A MX 2009000379 A MX2009000379 A MX 2009000379A
Authority
MX
Mexico
Prior art keywords
active ingredient
production
oral administration
small intestine
pharmaceutical preparation
Prior art date
Application number
MX2009000379A
Other languages
English (en)
Inventor
Gerd Jung
Albert Schaupp
Original Assignee
Pfleger R Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37496994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009000379(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfleger R Chem Fab filed Critical Pfleger R Chem Fab
Publication of MX2009000379A publication Critical patent/MX2009000379A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe una preparación farmacéutica para la administración oral con ingrediente activo de liberación controlada en el intestino delgado en la base de portadores de ingrediente activo con al menos un ingrediente activo que son proporcionados con una capa interna para la liberación controlada del ingrediente activo y una capa de recubrimiento, arreglada en los mismos, que es resistente a jugos gástricos y se caracteriza porque la capa interna está construida de por lo menos dos capas de difusión cuya permeabilidad para la difusión del ingrediente activo disminuye desde el interior hacia el exterior, y un método para su producción.
MX2009000379A 2006-07-10 2007-07-05 Preparacion farmaceutica para la administracion oral con liberacion controlada del ingrediente activo en el intestino delgado y metodo para su fabricacion. MX2009000379A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06014244A EP1880718B1 (de) 2006-07-10 2006-07-10 Pharmazeutische Zubereitung für die orale Verabreichung mit gesteuerter Wirkstofffreisetzung im Dünndarm und Verfahren zu ihrer Herstellung
PCT/EP2007/005970 WO2008006506A1 (de) 2006-07-10 2007-07-05 Pharmazeutische zubereitung für die orale verabreichung mit gesteuerter wirkstofffreisetzung im dünndarm und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
MX2009000379A true MX2009000379A (es) 2009-04-14

Family

ID=37496994

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009000379A MX2009000379A (es) 2006-07-10 2007-07-05 Preparacion farmaceutica para la administracion oral con liberacion controlada del ingrediente activo en el intestino delgado y metodo para su fabricacion.

Country Status (21)

Country Link
US (2) US8221787B2 (es)
EP (1) EP1880718B1 (es)
JP (1) JP5424877B2 (es)
KR (1) KR101451233B1 (es)
CN (1) CN101495103B (es)
AR (1) AR061860A1 (es)
AT (1) ATE525065T1 (es)
CA (1) CA2655838C (es)
CL (1) CL2007002000A1 (es)
DK (1) DK1880718T3 (es)
EA (1) EA016683B1 (es)
ES (1) ES2374158T3 (es)
HR (1) HRP20110739T1 (es)
IL (1) IL195931A (es)
JO (1) JO2801B1 (es)
MX (1) MX2009000379A (es)
PL (1) PL1880718T3 (es)
SI (1) SI1880718T1 (es)
TW (1) TWI375573B (es)
UA (1) UA95805C2 (es)
WO (1) WO2008006506A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009130712A2 (en) * 2008-04-22 2009-10-29 Lupin Limited Controlled release pharmaceutical compositions of trospium
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
WO2010043408A2 (de) * 2008-10-17 2010-04-22 Ratiopharm Gmbh Mikroverkapseltes fesoterodin
DE102009001636A1 (de) * 2009-03-18 2010-09-23 Henkel Ag & Co. Kgaa Bleichmittel mit verzögertem Bleichbeginn
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
AU2012296925A1 (en) * 2011-08-12 2014-02-06 Boehringer Ingelheim Vetmedica Gmbh Taste masked pharmaceutical composition
EP2790678A4 (en) * 2011-12-16 2015-09-30 Celanese Eva Performance Polymers Inc CONTROLLED RELEASE EXCIPIENTS COMPRISING ETHYLENE COPOLYMERS, ETHYLCELLULOSES AND / OR THERMOPLASTIC POLYURETHANES
JP2013145174A (ja) * 2012-01-13 2013-07-25 Panasonic Corp 近接センサ
CN107823721B (zh) * 2013-05-02 2021-01-29 德国凯德诺有限责任公司 球囊表面涂层
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
ITUA20161799A1 (it) * 2016-03-18 2017-09-18 Recordati Ind Chimica E Farmaceutica S P A Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale
US20220175812A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
JP3888064B2 (ja) * 2000-01-27 2007-02-28 田辺製薬株式会社 徐放性製剤およびその製法
CA2398199A1 (en) * 2000-01-28 2001-08-02 Asahi Kasei Kabushiki Kaisha Novel therapeutic agents that use a .beta.3 agonist
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
IN192159B (es) * 2000-05-15 2004-02-28 Ranbaxy Lab Ltd
US7229665B2 (en) * 2001-05-22 2007-06-12 Millipore Corporation Process of forming multilayered structures
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
AU2004289222B2 (en) * 2003-11-04 2010-01-21 Supernus Pharmaceuticals Inc. Compositions of quaternary ammonium containing bioavailability enhancers
US7410978B2 (en) * 2003-11-04 2008-08-12 Supernus Pharmaceuticals, Inc. Once daily dosage forms of trospium

Also Published As

Publication number Publication date
CL2007002000A1 (es) 2008-01-18
EA016683B1 (ru) 2012-06-29
IL195931A0 (en) 2009-09-01
PL1880718T3 (pl) 2012-02-29
EP1880718B1 (de) 2011-09-21
AR061860A1 (es) 2008-09-24
ES2374158T3 (es) 2012-02-14
CA2655838A1 (en) 2008-01-17
TWI375573B (en) 2012-11-01
JO2801B1 (en) 2014-03-15
JP2009542742A (ja) 2009-12-03
CN101495103A (zh) 2009-07-29
EA200970100A1 (ru) 2009-06-30
IL195931A (en) 2014-02-27
CA2655838C (en) 2014-04-08
SI1880718T1 (sl) 2011-11-30
DK1880718T3 (da) 2011-11-21
JP5424877B2 (ja) 2014-02-26
KR20090029830A (ko) 2009-03-23
UA95805C2 (uk) 2011-09-12
KR101451233B1 (ko) 2014-10-15
HK1109858A1 (en) 2008-06-27
HRP20110739T1 (hr) 2011-11-30
CN101495103B (zh) 2013-05-22
US20120294938A1 (en) 2012-11-22
US20090285891A1 (en) 2009-11-19
WO2008006506A1 (de) 2008-01-17
ATE525065T1 (de) 2011-10-15
TW200808381A (en) 2008-02-16
EP1880718A1 (de) 2008-01-23
US8221787B2 (en) 2012-07-17

Similar Documents

Publication Publication Date Title
UA95805C2 (uk) Фармацевтичний препарат для перорального прийому з контрольованим вивільненням активного інгрідієнта в тонкому кишечнику і спосіб його одержання
MX336789B (es) Farmacos resistentes al abuso, metodo de uso y metodo de fabricacion.
WO2010064139A3 (en) Zaleplon gastroretentive drug delivery system
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
TW200510001A (en) Dual drug dosage forms with improved separation of drugs
EP2076183A4 (en) DEVICES AND METHODS FOR ENDOLUMINAL MANIPULATION OF TISSUE DURING GASTRIC RESTRICTION AND DRUG DELIVERY
WO2008062440A3 (en) Programmable buoyant delivery technology
DE602007007991D1 (de) Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung
MX350871B (es) Vehiculo masticable para absorcion bucal.
WO2011101866A3 (en) Gastric retention formulation containing baclofen
PL2085078T3 (pl) Tabletka z lekami o dużej przenikalności będąca pompą osmotyczną o kontrolowanej porowatości oraz sposób jej wytwarzania
MX2012000948A (es) Anillo vaginal gradiente multicapas.
ATE540710T1 (de) Arzneimittel freisetzendes medizinprodukt und verfahren
WO2010020856A3 (en) Rate modulated delivery of drugs from a composite delivery system
WO2010103365A3 (en) Sustained release composition of therapeutic agent
WO2007144169A3 (en) Entacapone-derivatives
WO2012010669A3 (de) Arzneimittel zur oralen verabreichung umfassend ein gemisch aus silodosin und einem basischen copolymer
IN2014MN02526A (es)
WO2008120562A1 (ja) 帯状疱疹後神経痛治療用錠剤および帯状疱疹後神経痛の治療方法
RU2009101524A (ru) Способ лечения больных с дисбактериозом кишечника
WO2011153819A8 (zh) 用于戒毒的药物组合物
TH97797B (th) สารเตรียมทางเภสัชกรรมสำหรับการให้ยาทางปากที่มีการปลดปล่อยแบบควบคุมของสารออกฤทธิ์ในลำไส้เล็ก และวิธีสำหรับการผลิตของมัน
TH97797A (th) สารเตรียมทางเภสัชกรรมสำหรับการให้ยาทางปากที่มีการปลดปล่อยแบบควบคุมของสารออกฤทธิ์ในลำไส้เล็ก และวิธีสำหรับการผลิตของมัน
TW200744674A (en) Controlled-release single layer tablet of alfuzosin
WO2009024763A3 (en) Combination therapy

Legal Events

Date Code Title Description
FG Grant or registration